Patents by Inventor Bryan Walser

Bryan Walser has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PEANUT FORMULATIONS AND USES THEREOF
    Publication number: 20250375517
    Abstract: The present application relates to compositions for oral immunotherapy of peanut allergies. Further, the present application relates to methods for the preparation of the compositions for immunotherapy, and their use in immunotherapy.
    Type: Application
    Filed: June 7, 2024
    Publication date: December 11, 2025
    Inventors: Bryan WALSER, Howard V. RAFF
  • Peanut formulations and uses thereof
    Patent number: 12016917
    Abstract: The present application relates to compositions for oral immunotherapy of peanut allergies. Further, the present application relates to methods for the preparation of the compositions for immunotherapy, and their use in immunotherapy.
    Type: Grant
    Filed: April 7, 2020
    Date of Patent: June 25, 2024
    Assignee: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
    Inventors: Bryan Walser, Howard V. Raff
  • MANUFACTURE OF PEANUT FORMULATIONS FOR ORAL DESENSITIZATION
    Publication number: 20230120350
    Abstract: The present application relates to a method for managing the development and manufacturing process of a therapeutically effective formulation. Peanut proteins are characterized from peanut flour and encapsulated formulations made using the peanut flour for oral immunotherapy of peanut allergies.
    Type: Application
    Filed: September 20, 2022
    Publication date: April 20, 2023
    Inventors: Bryan Walser, Howard V. Raff
  • Manufacture of peanut formulations for oral desensitization
    Patent number: 11141352
    Abstract: The present application relates to a method for managing the development and manufacturing process of a therapeutically effective formulation. Peanut proteins are characterized from peanut flour and encapsulated formulations made using the peanut flour for oral immunotherapy of peanut allergies.
    Type: Grant
    Filed: June 26, 2019
    Date of Patent: October 12, 2021
    Assignee: Société des Produit Nestlé S.A.
    Inventors: Bryan Walser, Howard V. Raff
  • Methods for breast cancer risk assessment
    Patent number: 11072830
    Abstract: The present invention relates to methods and systems for assessing the overall risk of a human female subject for developing a breast cancer phenotype. In particular, the present invention relates to combining clinical risk assessment and genetic risk assessment to improve risk analysis.
    Type: Grant
    Filed: November 15, 2017
    Date of Patent: July 27, 2021
    Assignee: GENETIC TECHNOLOGIES LIMITED
    Inventors: David A. Hinds, Bryan Walser
  • PEANUT FORMULATIONS AND USES THEREOF
    Publication number: 20210052722
    Abstract: The present application relates to compositions for oral immunotherapy of peanut allergies. Further, the present application relates to methods for the preparation of the compositions for immunotherapy, and their use in immunotherapy.
    Type: Application
    Filed: April 7, 2020
    Publication date: February 25, 2021
    Applicant: Aimmune Therapeutics, Inc.
    Inventors: Bryan WALSER, Howard V. RAFF
  • Peanut formulations and uses thereof
    Patent number: 10653773
    Abstract: The present application relates to compositions for oral immunotherapy of peanut allergies. Further, the present application relates to methods for the preparation of the compositions for immunotherapy, and their use in immunotherapy.
    Type: Grant
    Filed: August 23, 2018
    Date of Patent: May 19, 2020
    Assignee: Aimmune Therapeutics, Inc.
    Inventors: Bryan Walser, Howard V. Raff
  • MANUFACTURE OF PEANUT FORMULATIONS FOR ORAL DESENSITIZATION
    Publication number: 20200129378
    Abstract: The present application relates to a method for managing the development and manufacturing process of a therapeutically effective formulation. Peanut proteins are characterized from peanut flour and encapsulated formulations made using the peanut flour for oral immunotherapy of peanut allergies.
    Type: Application
    Filed: June 26, 2019
    Publication date: April 30, 2020
    Applicant: Aimmune Therapeutics, Inc.
    Inventors: Bryan WALSER, Howard V. RAFF
  • Peanut formulations and used thereof
    Patent number: 10512686
    Abstract: The present application relates to compositions for oral immunotherapy of peanut allergies. Further, the present application relates to methods for the preparation of the compositions for immunotherapy, and their use in immunotherapy.
    Type: Grant
    Filed: February 28, 2019
    Date of Patent: December 24, 2019
    Assignee: Aimmune Therapeutics, Inc.
    Inventors: Bryan Walser, Howard V. Raff
  • Manufacture of peanut formulations for oral desensitization
    Patent number: 10449118
    Abstract: The present application relates to a method for managing the development and manufacturing process of a therapeutically effective formulation. Peanut proteins are characterized from peanut flour and encapsulated formulations made using the peanut flour for oral immunotherapy of peanut allergies.
    Type: Grant
    Filed: October 24, 2017
    Date of Patent: October 22, 2019
    Assignee: AIMMUNE THERAPEUTICS, INC.
    Inventors: Bryan Walser, Howard V. Raff
  • PEANUT FORMULATIONS AND USES THEREOF
    Publication number: 20190192652
    Abstract: The present application relates to compositions for oral immunotherapy of peanut allergies. Further, the present application relates to methods for the preparation of the compositions for immunotherapy, and their use in immunotherapy.
    Type: Application
    Filed: February 28, 2019
    Publication date: June 27, 2019
    Applicant: Aimmune Therapeutics, Inc.
    Inventors: Bryan WALSER, Howard V. RAFF
  • PEANUT FORMULATIONS AND USES THEREOF
    Publication number: 20190175723
    Abstract: The present application relates to compositions for oral immunotherapy of peanut allergies. Further, the present application relates to methods for the preparation of the compositions for immunotherapy, and their use in immunotherapy.
    Type: Application
    Filed: August 23, 2018
    Publication date: June 13, 2019
    Applicant: Aimmune Therapeutics, Inc.
    Inventors: Bryan WALSER, Howard V. RAFF
  • Peanut formulations and uses thereof
    Patent number: 10086068
    Abstract: The present application relates to compositions for oral immunotherapy of peanut allergies. Further, the present application relates to methods for the preparation of the compositions for immunotherapy, and their use in immunotherapy.
    Type: Grant
    Filed: September 26, 2016
    Date of Patent: October 2, 2018
    Assignee: Aimmune Therapeutics, Inc.
    Inventors: Bryan Walser, Howard V. Raff
  • METHODS FOR BREAST CANCER RISK ASSESSMENT
    Publication number: 20180080089
    Abstract: The present invention relates to methods and systems for assessing the overall risk of a human female subject for developing a breast cancer phenotype. In particular, the present invention relates to combining clinical risk assessment and genetic risk assessment to improve risk analysis.
    Type: Application
    Filed: November 15, 2017
    Publication date: March 22, 2018
    Applicant: Genetic Technologies Limited
    Inventors: David A. Hinds, Bryan Walser
  • MANUFACTURE OF PEANUT FORMULATIONS FOR ORAL DESENSITIZATION
    Publication number: 20180042816
    Abstract: The present application relates to a method for managing the development and manufacturing process of a therapeutically effective formulation. Peanut proteins are characterized from peanut flour and encapsulated formulations made using the peanut flour for oral immunotherapy of peanut allergies.
    Type: Application
    Filed: October 24, 2017
    Publication date: February 15, 2018
    Inventors: Bryan WALSER, Howard V. RAFF
  • PEANUT FORMULATIONS AND USES THEREOF
    Publication number: 20170021012
    Abstract: The present application relates to compositions for oral immunotherapy of peanut allergies. Further, the present application relates to methods for the preparation of the compositions for immunotherapy, and their use in immunotherapy.
    Type: Application
    Filed: September 26, 2016
    Publication date: January 26, 2017
    Applicant: Aimmune Therapeutics, Inc.
    Inventors: Bryan Walser, Howard V. Raff
  • Peanut formulations and uses thereof
    Patent number: 9492535
    Abstract: The present application relates to compositions for oral immunotherapy of peanut allergies. Further, the present application relates to methods for the preparation of the compositions for immunotherapy, and their use in immunotherapy.
    Type: Grant
    Filed: March 12, 2014
    Date of Patent: November 15, 2016
    Assignee: AIMMUNE THERAPEUTICS, INC.
    Inventors: Bryan Walser, Howard V. Raff
  • MANUFACTURE OF PEANUT FORMULATIONS FOR ORAL DESENSITIZATION
    Publication number: 20160030289
    Abstract: The present application relates to a method for managing the development and manufacturing process of a therapeutically effective formulation. Peanut proteins are characterized from peanut flour and encapsulated formulations made using the peanut flour for oral immunotherapy of peanut allergies.
    Type: Application
    Filed: October 13, 2015
    Publication date: February 4, 2016
    Inventors: Bryan WALSER, Howard V. RAFF
  • Manufacture of peanut formulations for oral desensitization
    Patent number: 9198869
    Abstract: The present application relates to a method for managing the development and manufacturing process of a therapeutically effective formulation. Peanut proteins are characterized from peanut flour and encapsulated formulations made using the peanut flour for oral immunotherapy of peanut allergies.
    Type: Grant
    Filed: March 12, 2014
    Date of Patent: December 1, 2015
    Assignee: Aimmune Therapeutics, Inc.
    Inventors: Bryan Walser, Howard V. Raff
  • MANUFACTURE OF PEANUT FORMULATIONS FOR ORAL DESENSITIZATION
    Publication number: 20140271836
    Abstract: The present application relates to a method for managing the development and manufacturing process of a therapeutically effective formulation. Peanut proteins are characterized from peanut flour and encapsulated formulations made using the peanut flour for oral immunotherapy of peanut allergies.
    Type: Application
    Filed: March 12, 2014
    Publication date: September 18, 2014
    Applicant: Allergen Research Corporation
    Inventors: Bryan Walser, Howard V. Raff